Global Naltrexone Market: Overview
According to the World Health Organization (WHO), substance abuse is usage of psychoactive substances, including alcohol and illicit drugs. Use of psychoactive substances could escalate to dependence syndrome (combination of behavioral, cognitive, and psychological phenomenon which forces an individual to use alcohol, nicotine, and illicit drugs). According to the WHO, in 2016, around 275 million people had used drugs at least once in their lifetime. According to the National Institute on Alcohol Abuse and Alcoholism, over 6% of the adult population suffered from alcohol use disorder in the U.S. in 2015. Naltrexone, commercialized under several brands such as Revia and Vivitrol, is primarily used to control opioid or alcohol dependence. However, all drugs are not available in all countries. For instance, the brand formulation of “Revia” had been discontinued in the U.S.; however, the generic Revia has been commercialized in the country.
Global Naltrexone Market: Key Trends
The global naltrexone market is driven by rise in alcohol & opioid dependence and high awareness about initiatives by medicine manufacturers and governments. However, strict regulatory constraints such as legal obligations for addiction treatment products in the developed countries is projected to hamper the growth of the global naltrexone market. Nevertheless, increase in research and development expenditure by major players, strategic alliances among key companies, and ongoing research on naltrexone drugs is anticipated to drive the global market during the forecast period.
Global Naltrexone Market: Segmentation
The global naltrexone market can be segmented based on product, dosage form, application, and end-user. In terms of product, the market can be bifurcated into branded and generic. Based on application, the global naltrexone market can be categorized into opioid dependence treatment, alcohol dependence treatment, and other applications such as pain management. In terms of dosage form, the market can be classified into tablet and injection. Based on end-user, the global naltrexone market can be divided into hospital pharmacies, retail pharmacies & drug stores, and online sales.
Global Naltrexone Market: Regional Analysis
Geographically, the global naltrexone market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America captured the largest share of the global market in 2018, owing to rise in opioid & alcohol treatment programs and increase in government initiatives to spread awareness about opioid/alcohol dependence. Europe held the second largest market share in 2018. The market in the region is projected to expand at a high CAGR in the near future. Opioid treatment with naltrexone is supported by government and private bodies in Europe, with a broad and diversified range of interventions. Additionally, the provision of outpatient treatment and support for treatment programs have increased considerably since 2010. Moreover, government initiatives to spread awareness about the increase in usage of opioids & alcohol and negative effects are expected to drive the naltrexone market in Europe during the forecast period.
The naltrexone market in Asia Pacific is expected to grow at a rapid pace in next few years. According to the China National Narcotics Control Commission 2015 report, heroin was the most abused drug in China. Therefore, the Government of China initiated various programs to spread awareness about drug addiction and its ill effects on society and personal life. According to a 2016 WHO report, there has been a substantial increase in treatment for abuse of other prescription drugs in Asia Pacific. These factors are likely to augment the naltrexone market in Asia Pacific during the forecast period. Less awareness about opioid/alcohol dependence treatment and inadequate health care infrastructure are projected to restrain the market in Latin America and Middle East & Africa during the forecast period.
Global Naltrexone Market: Competitive Landscape
Key companies in the global naltrexone market are Alkermes, Sun Pharmaceutical Industries Ltd., LGM Pharma, Mallinckrodt Pharmaceuticals, AdooQ BioScience, Abcam plc, and Intas Pharmaceutical Ltd., among others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.